Precision Medicine for Brain Disorders: New and Emerging Approaches

Zack Y. Shan; Jim Lagopoulos

doi:10.3390/jpm13050872

Back

Precision Medicine for Brain Disorders: New and Emerging Approaches

Editorial

Open access

Precision Medicine for Brain Disorders: New and Emerging Approaches

Zack Y. Shan and Jim Lagopoulos

Journal of Personalized Medicine, Vol.13(5), pp.1-3

2023

DOI: https://doi.org/10.3390/jpm13050872

PMCID: PMC10223554

PMID: 37241042

Appears in Thompson Institute Research Collection

Files and links (1)

pdf

jpm-13-00872177.40 kBDownload View

Published Version Open Access CC BY V4.0

Abstract

General mental health and psychology

Thompson Institute Special Collection

The brain is the most complex organ in the human body, making it susceptible to many abnormalities. Brain disorders include but are not limited to neurodegenerative brain diseases (Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis), mental illness (anxiety, bipolar disorder, depression, post-traumatic stress disorder, and schizophrenia), stroke, epilepsy, neurodevelopmental disorders (attention deficit hyperactivity disorder, autism spectrum disorder, and dyslexia), autoimmune brain diseases (multiple sclerosis and encephalitis), traumatic brain injuries and concussion, brain tumours (astrocytoma, glioblastoma, meningioma,), meningitis, myalgic encephalomyelitis/chronic fatigue syndrome, and hundreds of other rare brain diseases.

Details

Title: Precision Medicine for Brain Disorders: New and Emerging Approaches
Authors: Zack Y. Shan (Corresponding Author) - University of the Sunshine Coast, Queensland, Thompson Institute
Jim Lagopoulos (Author) - University of the Sunshine Coast, Queensland, Thompson Institute
Publication details: Journal of Personalized Medicine, Vol.13(5), pp.1-3
Publisher: MDPI AG
Date published: 2023
DOI: 10.3390/jpm13050872
ISSN: 2075-4426
PMID: 37241042; PMC10223554
Copyright note: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Grants: Multimodal MRI of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Understanding its Neuropathophysiology and Developing an Objective Neuromarker, 1184219, National Health and Medical Research Council (Australia, Canberra) - NHMRC
A multimodal neuromarker of myalgic encephalomyelitis/chronic fatigue syndrome, MAS2018F00024, The Mason Foundation
Organisation Unit: Thompson Institute
Language: English
Record Identifier: 99728398102621
Output Type: Editorial

Metrics

12 File views/ downloads

98 Record Views

3 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Web Of Science research areas: Health Care Sciences & Services

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: SDGs from InCites